[The effect of prolonged physical exercise on the binding capacity of beta-adrenergic lymphocyte receptors and their response in essential hypertension]. 1986

P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D004082 Dihydroalprenolol Hydrogenated alprenolol derivative where the extra hydrogens are often tritiated. This radiolabeled form of ALPRENOLOL, a beta-adrenergic blocker, is used to label the beta-adrenergic receptor for isolation and study. 1-((Methylethyl)amino)-3-(2-propylphenoxy)-2-propanol
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
January 1989, Clinical and experimental hypertension. Part A, Theory and practice,
P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
November 1988, Medicina clinica,
P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
August 1989, Acta physiologica Scandinavica,
P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
December 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
June 1985, Journal of clinical hypertension,
P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
February 1986, Nihon Kyobu Shikkan Gakkai zasshi,
P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
July 1993, The Annals of thoracic surgery,
P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
November 1983, International journal of sports medicine,
P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
March 1991, Alcoholism, clinical and experimental research,
P Prikryl, and V Vondrácek, and V Kunovská, and K Rysánek, and J Prásek, and J Dusek
October 1992, Acta paediatrica Japonica : Overseas edition,
Copied contents to your clipboard!